These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 27412252

  • 1. Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.
    Shaw KA, Bertha M, Hofmekler T, Chopra P, Vatanen T, Srivatsa A, Prince J, Kumar A, Sauer C, Zwick ME, Satten GA, Kostic AD, Mulle JG, Xavier RJ, Kugathasan S.
    Genome Med; 2016 Jul 13; 8(1):75. PubMed ID: 27412252
    [Abstract] [Full Text] [Related]

  • 2. Longitudinal Changes in Fecal Calprotectin Levels Among Pregnant Women With and Without Inflammatory Bowel Disease and Their Babies.
    Kim ES, Tarassishin L, Eisele C, Barre A, Nair N, Rendon A, Hawkins K, Debebe A, White S, Thjømøe A, Mørk E, Bento-Miranda M, Panchal H, Agrawal M, Patel A, Chen CL, Kornbluth A, George J, Legnani P, Maser E, Loudon H, Mella MT, Stone J, Dubinsky M, Sabino J, Torres J, Colombel JF, Peter I, Hu J, Mount Sinai Road to Prevention Study Group.
    Gastroenterology; 2021 Mar 13; 160(4):1118-1130.e3. PubMed ID: 33307026
    [Abstract] [Full Text] [Related]

  • 3. Profiles and interactions of gut microbiome and intestinal microRNAs in pediatric Crohn's disease.
    Lv Y, Zhen C, Liu A, Hu Y, Yang G, Xu C, Lou Y, Cheng Q, Luo Y, Yu J, Fang Y, Zhao H, Peng K, Yu Y, Lou J, Chen J, Ni Y.
    mSystems; 2024 Sep 17; 9(9):e0078324. PubMed ID: 39150251
    [Abstract] [Full Text] [Related]

  • 4. A microbial signature for Crohn's disease.
    Pascal V, Pozuelo M, Borruel N, Casellas F, Campos D, Santiago A, Martinez X, Varela E, Sarrabayrouse G, Machiels K, Vermeire S, Sokol H, Guarner F, Manichanh C.
    Gut; 2017 May 17; 66(5):813-822. PubMed ID: 28179361
    [Abstract] [Full Text] [Related]

  • 5. Faecal calprotectin assay after induction with anti-Tumour Necrosis Factor α agents in inflammatory bowel disease: Prediction of clinical response and mucosal healing at one year.
    Guidi L, Marzo M, Andrisani G, Felice C, Pugliese D, Mocci G, Nardone O, De Vitis I, Papa A, Rapaccini G, Forni F, Armuzzi A.
    Dig Liver Dis; 2014 Nov 17; 46(11):974-9. PubMed ID: 25096964
    [Abstract] [Full Text] [Related]

  • 6. Damage-associated molecular patterns in inflammatory bowel disease: From biomarkers to therapeutic targets.
    Nanini HF, Bernardazzi C, Castro F, de Souza HSP.
    World J Gastroenterol; 2018 Nov 07; 24(41):4622-4634. PubMed ID: 30416310
    [Abstract] [Full Text] [Related]

  • 7. Microbial Signatures and Innate Immune Gene Expression in Lamina Propria Phagocytes of Inflammatory Bowel Disease Patients.
    Dheer R, Davies JM, Quintero MA, Damas OM, Deshpande AR, Kerman DH, Sawyer WP, Pignac-Kobinger J, Ban Y, Fernandez I, Burgueno JF, Phillips MC, Abreu MT.
    Cell Mol Gastroenterol Hepatol; 2020 Nov 07; 9(3):387-402. PubMed ID: 31740421
    [Abstract] [Full Text] [Related]

  • 8. Dynamics of the human gut microbiome in inflammatory bowel disease.
    Halfvarson J, Brislawn CJ, Lamendella R, Vázquez-Baeza Y, Walters WA, Bramer LM, D'Amato M, Bonfiglio F, McDonald D, Gonzalez A, McClure EE, Dunklebarger MF, Knight R, Jansson JK.
    Nat Microbiol; 2017 Feb 13; 2():17004. PubMed ID: 28191884
    [Abstract] [Full Text] [Related]

  • 9. Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa.
    Reshef L, Kovacs A, Ofer A, Yahav L, Maharshak N, Keren N, Konikoff FM, Tulchinsky H, Gophna U, Dotan I.
    Gastroenterology; 2015 Sep 13; 149(3):718-27. PubMed ID: 26026389
    [Abstract] [Full Text] [Related]

  • 10. Dysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission.
    Pisani A, Rausch P, Bang C, Ellul S, Tabone T, Marantidis Cordina C, Zahra G, Franke A, Ellul P.
    Microbiol Spectr; 2022 Jun 29; 10(3):e0061622. PubMed ID: 35532243
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of mucosa-associated gut microbiota during treatment in Crohn's disease.
    He C, Wang H, Liao WD, Peng C, Shu X, Zhu X, Zhu ZH.
    World J Gastroenterol; 2019 May 14; 25(18):2204-2216. PubMed ID: 31143071
    [Abstract] [Full Text] [Related]

  • 12. Bacterial Taxa and Functions Are Predictive of Sustained Remission Following Exclusive Enteral Nutrition in Pediatric Crohn's Disease.
    Jones CMA, Connors J, Dunn KA, Bielawski JP, Comeau AM, Langille MGI, Van Limbergen J.
    Inflamm Bowel Dis; 2020 Jun 18; 26(7):1026-1037. PubMed ID: 31961432
    [Abstract] [Full Text] [Related]

  • 13. Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Palone F, Vitali R, Cucchiara S, Mennini M, Armuzzi A, Pugliese D, DʼIncà R, Barberio B, Stronati L.
    Inflamm Bowel Dis; 2016 Dec 18; 22(12):2886-2893. PubMed ID: 27755215
    [Abstract] [Full Text] [Related]

  • 14. Adolescent gut microbiome imbalance and its association with immune response in inflammatory bowel diseases and obesity.
    Joo M, Nam S.
    BMC Microbiol; 2024 Jul 19; 24(1):268. PubMed ID: 39030520
    [Abstract] [Full Text] [Related]

  • 15. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis.
    Maldonado-Arriaga B, Sandoval-Jiménez S, Rodríguez-Silverio J, Lizeth Alcaráz-Estrada S, Cortés-Espinosa T, Pérez-Cabeza de Vaca R, Licona-Cassani C, Gámez-Valdez JS, Shaw J, Mondragón-Terán P, Hernández-Cortez C, Suárez-Cuenca JA, Castro-Escarpulli G.
    Microbiologyopen; 2021 Mar 19; 10(2):e1181. PubMed ID: 33970546
    [Abstract] [Full Text] [Related]

  • 16. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
    Ma HQ, Yu TT, Zhao XJ, Zhang Y, Zhang HJ.
    World J Gastroenterol; 2018 Apr 07; 24(13):1464-1477. PubMed ID: 29632427
    [Abstract] [Full Text] [Related]

  • 17. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.
    Nishino K, Nishida A, Inoue R, Kawada Y, Ohno M, Sakai S, Inatomi O, Bamba S, Sugimoto M, Kawahara M, Naito Y, Andoh A.
    J Gastroenterol; 2018 Jan 07; 53(1):95-106. PubMed ID: 28852861
    [Abstract] [Full Text] [Related]

  • 18. Development of an Index Score for Intestinal Inflammation-Associated Dysbiosis Using Real-World Stool Test Results.
    Chen L, Reynolds C, David R, Peace Brewer A.
    Dig Dis Sci; 2020 Apr 07; 65(4):1111-1124. PubMed ID: 31529411
    [Abstract] [Full Text] [Related]

  • 19. Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease.
    Kostas A, Siakavellas SI, Kosmidis C, Takou A, Nikou J, Maropoulos G, Vlachogiannakos J, Papatheodoridis GV, Papaconstantinou I, Bamias G.
    World J Gastroenterol; 2017 Nov 07; 23(41):7387-7396. PubMed ID: 29151692
    [Abstract] [Full Text] [Related]

  • 20. IL23R-Protective Coding Variant Promotes Beneficial Bacteria and Diversity in the Ileal Microbiome in Healthy Individuals Without Inflammatory Bowel Disease.
    Zakrzewski M, Simms LA, Brown A, Appleyard M, Irwin J, Waddell N, Radford-Smith GL.
    J Crohns Colitis; 2019 Mar 30; 13(4):451-461. PubMed ID: 30445599
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.